{"id":1022,"slug":"有乳腺结节或乳腺癌家族史的人能做吗-长期安全性数据够不够","question":"有乳腺结节或乳腺癌家族史的人能做吗？长期安全性数据够不够？","intent":"informational","language":"zh","url":"https://worldwiki.io/q/有乳腺结节或乳腺癌家族史的人能做吗-长期安全性数据够不够","entity":{"slug":"svf-breast-augmentation","name":"SVF Breast Augmentation","url":"https://worldwiki.io/entity/svf-breast-augmentation"},"answer":{"short_answer":"现有资料给不出「能做/不能做」的结论，但明确指出了数据缺口：综述提出了基于VEGF/FGF信号通路的理论性肿瘤学担忧，并指出长期肿瘤学随访数据不足。同时，丰胸荟萃分析显示CAL与常规脂肪移植的并发症差异无统计学意义（OR 1.34）。因此有乳腺结节、乳腺癌家族史或既往乳腺疾病史的人，应先在国内乳腺外科评估并取得书面意见，再决定是否考虑该手术。","detailed_answer":"<p>三件应在决定前完成的事：</p><ol><li>在国内三级医院乳腺外科完成评估（超声/钼靶，必要时进一步检查），并保留报告；</li><li>向拟就诊机构书面询问：对有乳腺病史者的禁忌标准是什么、术前要求哪些检查、术后随访多久；</li><li>要求对方说明其长期随访数据的期限——现有可查的机构自报随访最长为18个月（n=102），肿瘤学长期数据在文献中被明确描述为不足。<sup>[1]</sup><sup>[9]</sup></li></ol><p>凡称「已证实不增加乳腺癌风险」的说法，均超出了上述来源能够支持的范围。</p>","format":"paragraph","confidence":55,"verified_at":null,"updated_at":"2026-09-20 17:11:10"},"sources":[{"id":284,"title":"Cell-Assisted Lipotransfer in Breast Augmentation Surgery: Clinical Outcomes and Considerations for Future Research","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8971120/","publisher":"Cureus (via PubMed Central)","type":"journal","accessed_at":"2026-09-19 18:00:45"},{"id":280,"title":"The Efficacy of Cell-Assisted Lipotransfer Versus Conventional Lipotransfer in Breast Augmentation: A Systematic Review and Meta-Analysis (Europe PMC record, PMID 33452543)","url":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1007/s00266-020-02123-0&format=json&resultType=core","publisher":"Aesthetic Plastic Surgery (via Europe PMC)","type":"journal","accessed_at":"2026-09-19 18:00:42"},{"id":27,"title":"A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384)","url":"https://pubmed.ncbi.nlm.nih.gov/36881737/","publisher":"Annals of Plastic Surgery","type":"academic","accessed_at":"2026-09-19 18:00:57"}],"published_at":"2026-09-20 08:11:10"}